Laparoscopic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is a safe and feasible procedure for selected patients with limited peritoneal disease. A retrospective analysis compared laparoscopic CRS-HIPEC to open CRS-HIPEC and found that laparoscopic procedures had lower estimated blood loss and overall morbidity rates. Grade III-IV complications, reintervention rates, and readmission rates were similar between the two groups. Additionally, patients treated with laparoscopic CRS-HIPEC had faster postoperative recovery and shorter hospital stays.
Journal Article by Bortoli N, Tonello M (…) Sommariva A et 3 al. in J Gastrointest Cancer
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.